EXACTCELL
Live / Applied — Statement of use — response to non-final action entered (as of 05 Jan 2026)
What this means for you
Not registered yet, but its 21 Jun 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98053248
- Mark type
- Stylized text
- Filed
- 21 Jun 2023
- Published for opposition
- 30 Jul 2024
- Attorney of record
- Anna Kurian Shaw
Goods and services
- Class 001 — Chemicals: Cells and biological tissue, namely, blood, lymphocytes, T cells, and T cell receptors, all for use in scientific, laboratory, and medical research; unmodified cells, all for use in scientific, laboratory, and medical research
- Class 005 — Pharmaceuticals: Biological and pharmaceutical preparations for treatment of viral infections and COVID-19
- Class 040 — Treatment of materials: Biomanufacturing for others, namely, custom manufacture of pharmaceuticals in the nature of T cells, using biological materials in the manufacturing process
Owner
- Tevogen Bio, Inc., Warren, NJ, US
- Tevogen Bio, Inc., Metuchen, NJ, US
Prosecution history
- 05 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 05 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 05 Jan 2026 — ASSIGNED TO LIE
- 15 Dec 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 14 Sept 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 14 Sept 2025 — NON-FINAL ACTION E-MAILED
- 14 Sept 2025 — SU - NON-FINAL ACTION - WRITTEN
- 25 Jun 2025 — ASSIGNED TO EXAMINER
- 09 Jun 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 12 Mar 2025 — USE AMENDMENT FILED
- 10 Jun 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 13 Mar 2025 — TEAS STATEMENT OF USE RECEIVED
- 24 Sept 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 30 Jul 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Jul 2024 — PUBLISHED FOR OPPOSITION